Work

A phase II trial of docetaxel plus carboplatin in hormone refractory prostate cancer (HRPC) patients who have progressed after prior docetaxel chemotherapy: Preliminary results

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.14533

Authors: W. K. Oh, J. Manola, R. W. Ross, A. Berkowitz, C. W. Ryan, K. M. Eilers, T. M. Beer

Institutions: Oregon Health & Science University, Dana-Farber Cancer Institute

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2280491699

Cites:

Cited by: 7

Related to: 10